NCT05632497

Brief Summary

The purpose of this study will be to study the association between the level of psychic symptomatic of anorexia nervosa (AN) (intensity of food restriction, symptoms of anxiety and depression) and alteration of host environment symbiosis and the mechanism (dysbiosis of intestinal microbiota, increase of intestinal permeability, immunity alteration and low-grade inflammation).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
5mo left

Started May 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
May 2024Oct 2026

First Submitted

Initial submission to the registry

November 14, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 30, 2022

Completed
1.5 years until next milestone

Study Start

First participant enrolled

May 23, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

November 24, 2025

Status Verified

November 1, 2025

Enrollment Period

2.3 years

First QC Date

November 14, 2022

Last Update Submit

November 19, 2025

Conditions

Keywords

Anorexia nervosaDysbiosisAnxious depressionIntestinal microbiotaBody mass index

Outcome Measures

Primary Outcomes (8)

  • Eating Disorder

    By Eating Disorder Inventory (EDI-3)

    at baseline

  • Anxio-depressive symptomatologic assessements by HAD score

    By HAD score

    at baseline

  • Anxio-depressive symptomatologic assessements by scale of Beck BDI 13

    By scale of Beck BDI 13

    at baseline

  • Anxio-depressive symptomatologic assessements by LSAS Lieboweitz social anxiety scale

    By LSAS Lieboweitz social anxiety scale

    at baseline

  • Anxio-depressive symptomatologic assessements by MOCI

    By Maudsley Obsessions and compulsions inventory (MOCI).

    at baseline

  • Anxio-depressive symptomatologic assessements

    By HAD score, scale of Beck BDI 13, LSAS Lieboweitz social anxiety scale, Maudsley Obsessions and compulsions inventory (MOCI).

    at baseline

  • Physical exercise

    By Global physical activity questionnaire (GPAQ)

    at baseline

  • Biological parameter

    By serum serotonin level

    at baseline

Secondary Outcomes (16)

  • Diversity indice

    at baseline

  • Intestinal permeability

    at baseline

  • Immunity alteration

    at baseline

  • Liver function

    at baseline

  • BMI

    at baseline

  • +11 more secondary outcomes

Study Arms (2)

Anorexia patients

Hospitalized anorexia patients with body mass index \< 15.

Biological: Stool and blood samples

Healthy controls

Health volunteers: 18 years or older with body mass index between 18.5 and 25.

Biological: Stool and blood samples

Interventions

Stool and blood samples

Anorexia patientsHealthy controls

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospitalized patients with anorexia nervosa for nutrition rehabilitation in the department of nutrition in Paul Brousse hospital (Villejuif) - APHP.

You may qualify if:

  • For patients:
  • Patients aged ≥18 years;
  • Anorexia according to DSM-5 and CIDI (Composite International Diagnostic Interview);
  • Body mass index (BMI) (P/T2) \< 15;
  • Hospitalization for nutrition rehabilitation;
  • Covered by a health insurance;
  • Informed consent form signed.
  • For Healthy Volunteers:
  • Aged ≥18 years;
  • \< BMI (P/T2) \< 25;
  • Covered by a health insurance;
  • Informed consent form signed.

You may not qualify if:

  • For patients:
  • Patients no-responding all criteria of DSM-5 or CIDI scores;
  • Taken of antibiotic treatment 2 months / or laxativ 3 weeks before hospitalization;
  • Somatic comorbidity should perturb intestinal microbiota (Crohn's disease, diabetes and all other chronic inflammatory diseases);
  • Patients under guardianship;
  • Patients covered by french AME scheme.
  • For Healthy Volunteers:
  • Any disease should perturb intestinal microbiota;
  • Recent ponderal variation;
  • Taken of antibiotic treatment 2 months or laxativ 3 weeks before hospitalization;
  • Under guardianship;
  • Covered by french AME scheme.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Nutrition Clinique, Hôpital Paul Brousse (APHP)

Villejuif, 94800, France

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Stool sample will be collected for all of 2 types of subjects (patients and health volunteers).

MeSH Terms

Conditions

Anorexia NervosaDysbiosis

Interventions

DefecationBlood Specimen Collection

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Digestive System Physiological PhenomenaDigestive System and Oral Physiological PhenomenaSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Mouna HANACHI GUIDOUM, MD

    Service de Nutrition Clinique, Hôpital Paul Brousse - APHP

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2022

First Posted

November 30, 2022

Study Start

May 23, 2024

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

November 24, 2025

Record last verified: 2025-11

Locations